UnitedHealth Group Incorporated (NYSE:UNH) Holdings Reduced by International Assets Investment Management LLC

International Assets Investment Management LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 95.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 218,350 shares of the healthcare conglomerate’s stock after selling 5,078,387 shares during the period. UnitedHealth Group accounts for about 5.0% of International Assets Investment Management LLC’s holdings, making the stock its 4th biggest holding. International Assets Investment Management LLC’s holdings in UnitedHealth Group were worth $110,455,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Innova Wealth Partners purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $455,000. Range Financial Group LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $285,000. One Wealth Capital Management LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $584,000. Diversified Trust Co lifted its position in UnitedHealth Group by 14.1% in the fourth quarter. Diversified Trust Co now owns 49,745 shares of the healthcare conglomerate’s stock valued at $25,164,000 after purchasing an additional 6,158 shares during the period. Finally, Bangor Savings Bank grew its holdings in shares of UnitedHealth Group by 7.5% in the 4th quarter. Bangor Savings Bank now owns 804 shares of the healthcare conglomerate’s stock worth $407,000 after acquiring an additional 56 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

UNH traded up $2.52 during trading on Wednesday, reaching $516.77. The stock had a trading volume of 429,260 shares, compared to its average volume of 3,178,334. The stock has a 50 day moving average of $557.79 and a two-hundred day moving average of $561.72. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a market capitalization of $475.58 billion, a price-to-earnings ratio of 33.67, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.56 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.63%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research reports. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, December 9th. Royal Bank of Canada decreased their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. UBS Group decreased their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Oppenheimer lifted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Finally, Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $627.58.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.